Should extra precautions be taken for pediatric oncology patients in light of the recent COVID-19 outbreak?

I have not personally seen cases. This is not surprising, however, because our patient population is more susceptible to severe outcomes from respiratory infections. This is compounded by weakened immune function and, for some patients, cardio respiratory damage.

Not much literature in pediatric oncology patients, yet (and hopefully cases will be kept small).

Although I have not had any ped patients recently, newer low-level evidence suggests young children (~<= 5 yrs) may develop more severe symptoms [1] and other studies (including the low-n Lancet article)...